MedPath

Molindone

Generic Name
Molindone
Drug Type
Small Molecule
Chemical Formula
C16H24N2O2
CAS Number
7416-34-4
Unique Ingredient Identifier
RT3Y3QMF8N

Overview

An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of clozapine. (From AMA Drug Evaluations Annual, 1994, p283)

Background

An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of clozapine. (From AMA Drug Evaluations Annual, 1994, p283)

Indication

Molindone is used for the management of the manifestations of psychotic disorders.

Associated Conditions

  • Schizophrenia

FDA Approved Products

Molindone Hydrochloride
Manufacturer:EPIC PHARMA, LLC
Route:ORAL
Strength:5 mg in 1 1
Approved: 2019/10/31
NDC:42806-336
Molindone Hydrochloride
Manufacturer:EPIC PHARMA, LLC
Route:ORAL
Strength:10 mg in 1 1
Approved: 2019/10/31
NDC:42806-337
Molindone Hydrochloride
Manufacturer:EPIC PHARMA, LLC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2019/10/31
NDC:42806-338

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath